Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Gomez

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Respiratory Medicine and Research|January 11, 2023
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2021 update. Full-length versionVincent Cottin, Philippe Bonniaud, Jacques Cadranel, et al.
ERJ Open Research|January 5, 2023
COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre studySpyros A Papiris, Ilaria Campo, Francesca Mariani, et al.
The Lancet. Respiratory Medicine|September 10, 2021
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trialJean-Marc Naccache, Stéphane Jouneau, Morgane Didier, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Respiratory Medicine and Research|January 11, 2023
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2021 update. Full-length versionVincent Cottin, Philippe Bonniaud, Jacques Cadranel, et al.
ERJ Open Research|January 5, 2023
COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre studySpyros A Papiris, Ilaria Campo, Francesca Mariani, et al.
The Lancet. Respiratory Medicine|September 10, 2021
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trialJean-Marc Naccache, Stéphane Jouneau, Morgane Didier, et al.
Pageof 4